Developed by Ascentage Pharma, lisaftoclax is a novel orally available Bcl-2 inhibitor with clinical benefits for an array of hematologic malignancies and solid tumors. At this year's ASH Annual ...
Mzansi was concerned about their oral hygiene after receiving new dentist-recommended information on hoe to properly brush teeth without rinsing the mouth.